Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Robert F. Kennedy Jr., a prominent vaccine critic, was confirmed Thursday by the U.S. Senate in a 52-48 vote to serve as the ...

MoneyShow presents top investment ideas for 2024 from leading advisors. Part 10 includes Advanced Micro Devices, Novo Nordisk ...

CR tested 58 dog foods from brands including Blue Buffalo, Hill’s Science Diet, and Purina for key nutrients and dangerous ...

USDA finally has a new secretary, and Robert F. Kennedy Jr. is bringing his MAHA priorities to the federal government as ...

New report from Sperling's BestPlaces and Medtronic highlights the cities they may call home NORTHAMPTON, MA / ACCESS Newswire / February 11, 2025 / Scientists are now speculating that the first perso ...

Background Cardiovascular disease (CVD) remains a significant public health challenge in China. This study aimed to project ...

Talk privacy and network with local members at IAPP KnowledgeNet Chapter meetings, taking place worldwide. IAPP Job Board Looking for a new challenge, or need to hire your next privacy pro? The IAPP ...

Solana jumped more than 10% in response to the announcement, and its technical chart shows strongly bullish ... the year that decentralization becomes a major part of the conversation, as the citizens ...

Scientists mapped fat tissue differences in obese individuals, uncovering cell changes linked to metabolic disease risk and ...

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.